These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

41 related items for PubMed ID: 18687501

  • 21. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA.
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [Abstract] [Full Text] [Related]

  • 22. Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride.
    Ebato C, Shimizu T, Arakawa M, Mita T, Fujitani Y, Watada H, Kawamori R, Hirose T.
    Diabetes Res Clin Pract; 2009 Oct; 86(1):31-6. PubMed ID: 19692134
    [Abstract] [Full Text] [Related]

  • 23. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 24. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [Abstract] [Full Text] [Related]

  • 25. [Monitoring hypoglycemia in elderly diabetic patients: a prospective study].
    Coutaz M, Nicod M, Chassot M, Morisod J.
    Rev Med Suisse; 2007 Apr 25; 3(108):1071-6. PubMed ID: 17552260
    [Abstract] [Full Text] [Related]

  • 26. Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis.
    Czech M, Rdzanek E, Pawęska J, Adamowicz-Sidor O, Niewada M, Jakubczyk M.
    BMC Endocr Disord; 2015 Oct 12; 15():57. PubMed ID: 26458540
    [Abstract] [Full Text] [Related]

  • 27. Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.
    Liebl A, Prusty V, Valensi P, Kawamori R, Christiansen JS, Palmer AJ, Balschmidt P, Ligthelm R, Mohan V.
    Drugs; 2012 Jul 30; 72(11):1495-520. PubMed ID: 22818015
    [Abstract] [Full Text] [Related]

  • 28. Glycaemic control and hypoglycaemia in the PRESENT study.
    Almustafa M, Yeo JP, Khutsoane D.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S10-5. PubMed ID: 18687501
    [Abstract] [Full Text] [Related]

  • 29. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 30; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 30. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 30; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 31. Study design and baseline characteristics of patients in the PRESENT study.
    Shestakova M, Bech OM, Momani MS.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S3-9. PubMed ID: 18672309
    [Abstract] [Full Text] [Related]

  • 32. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group.
    Diabetes Obes Metab; 2008 Mar 30; 10(3):212-22. PubMed ID: 18269636
    [Abstract] [Full Text] [Related]

  • 33. Glycaemic control and hypoglycaemia in the PRESENT study.
    Almustafa M, Yeo JP, Khutsoane D.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S10-5. PubMed ID: 18687501
    [Abstract] [Full Text] [Related]

  • 34. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 30; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 35. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 30; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 36. Study design and baseline characteristics of patients in the PRESENT study.
    Shestakova M, Bech OM, Momani MS.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S3-9. PubMed ID: 18672309
    [Abstract] [Full Text] [Related]

  • 37. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group.
    Diabetes Obes Metab; 2008 Mar 30; 10(3):212-22. PubMed ID: 18269636
    [Abstract] [Full Text] [Related]

  • 38. Glycaemic control and hypoglycaemia in the PRESENT study.
    Almustafa M, Yeo JP, Khutsoane D.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S10-5. PubMed ID: 18687501
    [Abstract] [Full Text] [Related]

  • 39. Study design and baseline characteristics of patients in the PRESENT study.
    Shestakova M, Bech OM, Momani MS.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S3-9. PubMed ID: 18672309
    [Abstract] [Full Text] [Related]

  • 40. Glycaemic control and hypoglycaemia in the PRESENT study.
    Almustafa M, Yeo JP, Khutsoane D.
    Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S10-5. PubMed ID: 18687501
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.